ELIZA CREEDON: Open Payments
NPI 1407534522 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 39 payments from 14 companies in 2025. Trend: 2023 $441 · 2024 $722 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $150 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Janssen Pharmaceuticals, Inc | 3 | $63 |
| Corium, LLC | 3 | $59 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| Neurocrine BioSciences, Inc. | 1 | $39 |
| JAZZ PHARMACEUTICALS INC. | 1 | $38 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Tris Pharma Inc | 1 | $21 |
Products named: VRAYLAR, CAPLYTA, INVEGA SUSTENNA, Azstarys, FANAPT, INGREZZA, XYWAV, COBENFY.
Industry payments across TX — which companies pay providers there.
